Skin cancer is often overlooked by many Americans, who are at elevated risk for being over exposed to the sun in the summer ...

Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...

Results from the Phase III VERITAC-2 trial demonstrated that vepdegestrant reduced the risk of disease progression or death ...

Fidelis Care announced that it is using Men’s Health Month as an opportunity to promote important health tips that men should ...

The drinks contain a mix of protein and vitamins that will help GLP-1 users reduce weight in a healthy manner.

These diseases require specialty treatment typically unavailable at local retail pharmacies or small health systems, making ...

New drug application submission was based on positive data from the Phase III GLISTEN trial, which demonstrated significant ...

Approval was based on results from the Phase III ARANOTE trial, in which Nubeqa demonstrated a 46% reduction in the risk of ...

Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

The industry is facing challenges from the new administration that could have serious impacts on everything from market ...

In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good ...

Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.